Diet Drug Belviq Withdrawn Due to Cancer Risk

overweight woman in gym

The FDA asked the maker of weight-loss drug Belviq (lorcaserin) to take it off the market after a clinical trial showed an association with an increased risk of cancer.

Written by Newport Beach Compounding Center Staff

As one of the most experienced compounding pharmacies in Newport Beach, We provide a valuable service working together with physicians and patients to create medications tailored to specific requirements. We are specialists in the art and science of pharmacy compounding. Our Team of experts can meet all of your unique pharmaceutical needs.

No Comments Yet.

Leave a Reply

You must be logged in to post a comment.